Latest ABCA1 Stories
BANGALORE, India, June 9, 2014 /PRNewswire/ -- Clinigene International Ltd, a subsidiary of Syngene International Ltd, India's leading Contract Research Services provider,
LA JOLLA, Calif., June 6, 2011 - Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced publication in the Journal of Clinical Investigation of new pre-clinical data in mice on the antagonism of microRNA-33 (miR-33).
Study identifies potential new strategy for raising 'good' cholesterol levels.
A large genetic study of age-related macular degeneration (AMD) has identified three new genes associated with this blinding eye diseaseâ€”two involved in the cholesterol pathway.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia.
NEW ORLEANS, LA, Nov. 10 /PRNewswire-FirstCall/ -- Resverlogix Corp. ("Resverlogix") (TSX:RVX) is pleased to announce today key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting.
- A woman chauffeur.
- A woman who operates an automobile.